- Home
- GDTC vs BODI Comparison
GDTC vs BODI Comparison
Compare GDTC & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- BODI
- Stock Information
- Founded
- GDTC 2018
- BODI 1998
- Country
- GDTC Singapore
- BODI United States
- Employees
- GDTC N/A
- BODI N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- BODI Industrial Machinery/Components
- Sector
- GDTC Health Care
- BODI Industrials
- Exchange
- GDTC Nasdaq
- BODI Nasdaq
- Market Cap
- GDTC 33.4M
- BODI 38.8M
- IPO Year
- GDTC 2023
- BODI N/A
- Fundamental
- Price
- GDTC $2.38
- BODI $6.51
- Analyst Decision
- GDTC Buy
- BODI Strong Buy
- Analyst Count
- GDTC 1
- BODI 3
- Target Price
- GDTC $5.00
- BODI $12.33
- AVG Volume (30 Days)
- GDTC 597.0K
- BODI 17.4K
- Earning Date
- GDTC 01-01-0001
- BODI 03-10-2025
- Dividend Yield
- GDTC N/A
- BODI N/A
- EPS Growth
- GDTC N/A
- BODI N/A
- EPS
- GDTC N/A
- BODI N/A
- Revenue
- GDTC $330,254.00
- BODI $451,432,000.00
- Revenue This Year
- GDTC $14.71
- BODI N/A
- Revenue Next Year
- GDTC N/A
- BODI N/A
- P/E Ratio
- GDTC N/A
- BODI N/A
- Revenue Growth
- GDTC N/A
- BODI N/A
- 52 Week Low
- GDTC $1.20
- BODI $5.14
- 52 Week High
- GDTC $4.30
- BODI $12.13
- Technical
- Relative Strength Index (RSI)
- GDTC 44.91
- BODI 51.94
- Support Level
- GDTC $2.12
- BODI $5.45
- Resistance Level
- GDTC $2.64
- BODI $7.50
- Average True Range (ATR)
- GDTC 0.48
- BODI 0.58
- MACD
- GDTC -0.10
- BODI 0.04
- Stochastic Oscillator
- GDTC 13.47
- BODI 51.71
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.